Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06445127 · ClinicalTrials.gov registry record
Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)
A clinical trial, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- 15
- Enrollment target
NCT06445127: Clinical Trial study, sponsored by Johns Hopkins University.
NCT06445127 is a clinical trial that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06445127 was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- 15 participants
- Enrollment target
Study Summary
This study is being done to find out if a non-invasive Magnetic Resonance Imaging (MRI) examination of the kidneys may be helpful in patients with systemic lupus erythematosus (SLE).
Primary Outcome
The presence of inflammation within both kidneys will be measured using MRI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-05-07 |
| Est. Completion | 2025-04-08 |
Why NCT06445127 stopped before completion
NCT06445127 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT06445127 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06445127 about?
NCT06445127 is a clinical study titled "Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)". This study is being done to find out if a non-invasive Magnetic Resonance Imaging (MRI) examination of the kidneys may be helpful in patients with systemic lupus erythematosus (SLE).
What is the current status of trial NCT06445127?
This trial is currently terminated. The enrollment target is 15 participants. The study started on 2024-05-07. Estimated completion is 2025-04-08.
Who is sponsoring clinical trial NCT06445127?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI